POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
UNI - EN REPORT No | 42 | / | 2016 | ||||||||
Date of issue: | 2016-05-03 | ||||||||||
Short name of the issuer | |||||||||||
SOPHARMA AD | |||||||||||
Subject | |||||||||||
NOTIFICATION OF INSIDERS’ TRANSACTIONS | |||||||||||
Official market - legal basis | |||||||||||
Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osуb maj№cych dostкp do informacji poufnych | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
Sopharma AD (the “Company") announces that it was notified by Mr. Ognian Donev, Chairman of the Board of Directors that the company “Sopharma Trading AD" related to him, executed the following transactions related to shares in the Company: Date and time of the settlement Operation Number of shares Unit price (BGN) 27.4.2016 Buy 400 2.6600 3.5.2016 Buy 500 2.6850 3.5.2016 Buy 1 000 2.6660 3.5.2016 Buy 560 2.6210 3.5.2016 Buy 185 2.6660 3.5.2016 Buy 114 2.6850 3.5.2016 Buy 400 2.6850 4.5.2016 Buy 500 2.7000 4.5.2016 Buy 500 2.6950 4.5.2016 Buy 400 2.6630 The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade. | |||||||||||
Annexes | |||||||||||
File | Description | ||||||||||
SPHTRCurrent report 42 re insiders transactions.doc | NOTIFICATION OF INSIDERS’ TRANSACTIONS |
SOPHARMA AD | |||||||||||||
(fullname of the issuer) | |||||||||||||
SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
1220 | Sofia | ||||||||||||
(post code) | (city) | ||||||||||||
IlienskoShosse | 16 | ||||||||||||
(street) | (number) | ||||||||||||
+359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
nd | |||||||||||||
(NIP) | (REGON) |
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2016-05-03 | Ognian Donev | Executive Director |